Chronic treatment regimen using glucagon-like insulinotropic peptides

Details for Australian Patent Application No. 2002239384 (hide)

Owner Eli Lilly and Company

Inventors Mace, Kenneth Francis; Trautmann, Michael Ernst; Dodd, Steven Witt

Agent Wrays

Pub. Number AU-B-2002239384

PCT Pub. Number WO02/47716

Priority 60/298,652 15.06.01 US; 60/295,655 04.06.01 US; 60/255,251 13.12.00 US

Filing date 7 December 2001

Wipo publication date 24 June 2002

Acceptance publication date 11 January 2007

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07K 14/605 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

11 January 2007 Application Accepted

  Published as AU-B-2002239384

17 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002239385-A SELF-CLEANING OPTIC FOR EXTREME ULTRAVIOLET LITHOGRAPHY

2002239383